GlassScriptPhysician profile
Philip Green
NPI 1275675027
$93,935.72
in general payments reported to CMS, 2019-2025
43 companies · $3,046 in 2025
The $3,046 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74K · 2020: $9,274 · 2021: $1,780 · 2022: $986 · 2023: $4,238 · 2024: $1,074 · 2025: $3,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,142 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,600 · Consulting Fee: $450 · Entertainment: $148 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,142.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,600.00 |
| Consulting Fee | $450.00 |
| Entertainment | $148.26 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $26,706.67 | 2019-2023 | Diamondback Peripheral |
| Pfizer INC. | $17,162.55 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $13,491.46 | 2019 | |
| Abbott Laboratories | $8,080.10 | 2019-2025 | Diamondback Peripheral, Absolute Pro, Diamondback Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6,009.64 | 2019-2020 | |
| Edwards Lifesciences Corporation | $4,458.09 | 2019-2024 | Sapien 3 Ultra Resilia |
| Ekos Corporation | $3,579.10 | 2019 | |
| Endologix LLC | $2,556.43 | 2019-2020 | |
| Angiodynamics, INC. | $2,328.86 | 2019 | |
| Heartflow, INC. | $1,337.72 | 2019-2025 | Ffrct |
| Inari Medical, INC. | $1,335.18 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $1,333.44 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Clottriever Bold Catheter |
| Boston Scientific Corporation | $1,270.72 | 2019-2025 | General - Therapies, Avvigo Guidance System |
| Cardiva Medical, INC. | $876.82 | 2019-2020 | |
| Change Healthcare Technologies, LLC | $450.00 | 2025 | Change Healthcare Cardiology |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $375.86 | 2019-2025 | Venovo, Presto, Lutonix Drug Coated Balloon |
| Medtronic, INC. | $367.07 | 2021-2025 | Endurant Iis, Closurefast, Hawkone |
| Terumo Medical Corporation | $313.96 | 2020-2025 | Metacross Otw, Glidewire, Tr Band |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.05 | 2019-2022 | |
| Abiomed | $199.82 | 2019 | |
| Silk Road Medical, INC. | $168.41 | 2021 | |
| Opsens INC. | $148.26 | 2023 | Optowire |
| Siemens Medical Solutions USA, INC. | $148.01 | 2019 | |
| Shockwave Medical, INC | $130.71 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Tactile Systems Technology INC | $118.43 | 2021-2025 | Flexitouch Plus, Nimbl |
| Teleflex LLC | $106.00 | 2020 | |
| Amgen INC. | $102.46 | 2020-2023 | Repatha |
| Medtronic Vascular, INC. | $101.96 | 2020 | |
| Novartis Pharmaceuticals Corporation | $90.29 | 2024-2025 | |
| Esperion Therapeutics, INC. | $55.54 | 2024-2025 | Nexletol |
| Veryan Medical Incorporated | $48.99 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $45.89 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $38.15 | 2019-2023 | Xarelto |
| Cook Medical LLC | $36.45 | 2025 | Zilver Vena |
| Davol INC. | $28.07 | 2025 | Venovo |
| Amarin Pharma, INC. | $22.91 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $19.00 | 2023 | Inpefa |
| Bardy Diagnostics, INC. | $15.02 | 2022 | |
| Cagent Vascular INC | $14.93 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.94 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.26 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.25 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.